Deconstructing Workflows: Breaking tradition to breakthrough new therapies
The pharmaceutical industry is undergoing a significant transformation driven by numerous factors. These include the need for greater R&D efficiency, reducing expenditure for in-market assets to refresh the pipeline and adapting to a more diversified knowledge exchange ecosystem — all calling for greater efficiency. Within this transformation, the role of medical affairs teams and the challenges these teams face are changing. Medical affairs teams are increasingly challenged to do more with less, managing a growing number of assets with shrinking budgets and tighter timelines.
In this eBook you’ll learn about:
- Breaking tradition through new therapies
- Why traditional workflows need optimization
- The impact of optimized workflows in achieving better outcomes
- Case study: Oncology literature review and insights generation
Download the eBook.
Jump to a slide with the slide dots.
AI in clinical trials: How AI is optimizing trial design, safety, and drug development
Discover how AI can significantly accelerate drug development by enhancing various aspects of clinical trial design in this article.
Read more2025 data, tech, and AI trends: What you need to know.
In this report, Inizio experts provide key updates on how human partnership with AI has been used to create value at pivotal moments, driving commerci
Read moreThe future of HCP engagement: 4 priorities and strategies
Inizio Engage conducted an independent market research study to explore the future of engagement with HCPs.
Read more